When was Sim and Cure founded?

Sim and Cure was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Sim and Cure located?

Sim and Cure is headquartered in Montpellier, France. It is registered at Rue Pierre Flourens, Bâtiment H 95 34090 Montpellier.

Who is the current CEO of Sim and Cure?

Mathieu Sanchez of Sim and Cure.

How many employees does Sim and Cure have?

As of Aug 31, 2026, the latest employee count at Sim and Cure is 63.

Is Sim and Cure a funded company?

Sim and Cure is a funded company, having raised a total of $15.3M across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 2015.

When was the latest funding round of Sim and Cure?

Sim and Cure's latest funding was a $***** Series A round on Nov 28, 2025, with participation from 2 investors. Its primary sector is Healthcare IT. In France, the Healthcare IT sector has seen $262M in funding in 2026 to date.

Where does Sim and Cure rank among its competitors?

Sim and Cure ranks 2nd amongst 75 active competitors, of which 25 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was SentiAR, which secured $1.48M in Apr, 2026.

Who are the top competitors of Sim and Cure?

Sim and Cure's top competitors include LensAR, AVATAR MEDICAL and CairnSurgical. Among them, SentiAR secured the most recent funding round in April, 2026.

Sim and Cure - 2026 Company Profile, Team, Funding & Competitors

Company Details

Sim and Cure, SA develops software that helps in planning endovascular treatment and optimizing medical devices. Their software is a kind of Google Maps for neuro-radiologists in terms of helping them to find the best type, position, and size of the medical device for each patient. It offers a Cerebral Device size (CDsize), a software solution that helps clinicians to find the optimal size of the cerebral medical device for patients; and FlowDiverterSize (FDsize), a CDsize module to find the position and size to treat a cerebral aneurysm.The simulation software FDSize is able to predict the final deployment of a flow-diverter from angiographic DICOM data.

Website: sim-and-cure.com
Social
Registered Address: Rue Pierre Flourens, Bâtiment H 95 34090 Montpellier

Key Metrics

Founded Year

2014

Location

Montpellier, France

Stage

Series A

Total Funding

$15.3M in 4 rounds

Latest Funding Round

Series A, Nov 28, 2025, $*****

Investors

Elaia & 4 more

Ranked

2^nd among 75 active competitors

Employee Count

63 as on Aug 31, 2026

Similar Companies

LensAR & 85 more

View Sim and Cure's full profile

Sim and Cure is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sim&cure CIN: 1003.260.805 , Belgium, Active	Dec 11, 2023	-	-	-

Sim and Cure has raised a total funding of $15.3M over 4 rounds. Its first funding round was on Jun 2015. Its latest funding round was a Series A round on Nov 28, 2025 for $*****. 2 investors participated in its latest round. Sim and Cure has 5 institutional investors.

Here is the list of recent funding rounds of Sim and Cure:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 28, 2025	4279897	Series A	1370237	6983583	1206977	5746472
May 23, 2019	6426297	Series A	2404483	7521810	4972266	IT-Translation
Dec 2015	2156958	Seed	7472885	1977750	IT-Translation	3384028

Access funding benchmarks and valuations. Sign up today!

View details of Sim and Cure's funding rounds and investors

The founders of Sim and Cure is Mathieu Sanchez.

Here are the details of Sim and Cure's key team members:

Mathieu Sanchez: CEO & Co-Founder of Sim and Cure.

View details of Sim and Cure's Founder profiles and Board Members

Sim and Cure's employee count trend

Sim and Cure has 63 employees as of Aug 26. Here is Sim and Cure's employee count trend over the years:

Uncover Sim and Cure's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sim and Cure include LensAR, AVATAR MEDICAL and CairnSurgical. Here is the list of Top 10 competitors of Sim and Cure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	LensAR 2004, Orlando (United States), Acquired	Laser Technology with AR feature for cataract surgery	$99M	Aisling Capital, Florida Growth Capital & 3 others	64/100
2nd	Sim and Cure 2014, Montpellier (France), Series A	Designs new generations software to improve neurovascular planning process	$15.3M	Elaia, IT-Translation & 3 others	55/100
3rd	AVATAR MEDICAL 2020, Paris (France), Seed	Provider of a virtual reality assistant for surgeons	$5.39M	GO CAPITAL, Acorn Pacific Ventures & 7 others	54/100
4th	CairnSurgical 2015, Lebanon (United States), Series A	Developer of 3D printed surgical guides for breast cancer treatment	$7.79M	Morningside Ventures, Morningside & 5 others	54/100
5th	Realview Imaging 2008, Yokneam Illit (Israel), Series C	Provides 3D holographic display based solutions for medical imaging applications	$25M	OurCrowd, ADIP & 10 others	49/100
6th	SentiAR 2017, St. Louis (United States), Series B	Provider of a 3D visualization platform for interventional cardiac procedures	$28.2M	cultivate(MD), Cultivation Capital & 15 others	48/100
7th	Biomodex 2014, Paris (France), Acquired	3D printed surgical simulators for medical education and patient-specific preoperative planning	$18.6M	Idinvest Partners, Innovation Capital & 6 others	47/100
8th	EDDA Technology 2003, Series D	Developer of software for medical imaging analysis and surgical planning	$150M	SoftBank Vision Fund	47/100
9th	inHEART 2017, Pessac (France), Series B	AI-based 3D cardiac models for therapeutic planning for providers	$15.2M	Elaia, Aquitaine Science Transfert & 6 others	47/100
10th	Disior 2016, Espoo (Finland), Acquired	Software for bone fracture analysis and treatment planning	$2.94M	Maki, Tesi & 1 others	46/100